Edit |   |
---|---|
Antigenic Specificity | CD184, Human (Ulocuplumab biosimilar) |
Clone | Ulocuplumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD184 Recombinant Antibody. Ulocuplumab (INN, development code MDX-1338) is a monoclonal antibody designed for the treatment of hematologic malignancies.This drug was developed by Bristol-Myers Squibb. |
Immunogen | n/a |
Other Names | Anti-CD184 Recombinant Antibody, Research Grade Ulocuplumab, Anti-Human CD184 Recombinant Antibody, BMS-936564, MDX-1338, Antibody Drug Analogues, Monoclonal Antibody, YR1325, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1375830-34-4 |
Catalog # | YR1325 |
Price | please inquire |
Order / More Info | CD184, Human (Ulocuplumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |